Highlights
- Bubs Australia (ASX:BUB) reports significant earnings turnaround.
- Gross revenue up 42%, signaling strong growth.
- Positive FY25 guidance maintained, showcasing confidence in future prospects.
Bubs Australia (ASX:BUB) witnessed an impressive 22% surge in its stock price on Wednesday, following an optimistic earnings report for the first half of the 2025 financial year. The company, which specializes in infant nutrition and other related products, announced a remarkable recovery in its financials compared to the same period last year.
For the first half of FY2025, Bubs Australia reported earnings before interest, taxes, depreciation, and amortization (EBITDA) of $2.9 million, marking a significant improvement from the $6.8 million loss recorded in the same period of FY2024. This growth highlights the company’s successful turnaround, building investor confidence as it continues to recover from previous challenges.
In addition to the recovery in earnings, Bubs Australia showcased positive cash flow management, with a reported operating cash flow of $3.9 million for the second quarter. This marked an impressive shift from the $13 million outflow reported during the same period last year, a clear sign that the company’s financial stability has vastly improved.
The strong results were complemented by an increase in gross revenue for the quarter, reaching $32.9 million. This reflects a solid 42% rise from the previous year, signaling strong growth and demand for Bubs’ products. The company has also reaffirmed its revenue forecast for FY25, aiming for a projected $102 million in total revenue, with gross margins expected to exceed 40%. Furthermore, Bubs remains on track to achieve breakeven EBITDA by the end of the financial year.
In response to these strong financials, Bubs’ stock rallied sharply, with shares up 22.5% to 12¢ by lunchtime on Wednesday. This significant boost in stock value reflects the market's positive reception of the company’s ability to recover and sustain growth.
Looking ahead, Bubs Australia is well-positioned to continue its upward trajectory, with clear goals set for the remainder of the year and an optimistic outlook for the future. Investors and market watchers will likely keep a close eye on the company’s progress as it works to capitalize on its recovery and growth potential.